Genomma Lab Internacional, S.A.B. de C.V. GNMLF
0.84 USD 0.00 (+0.00%)
At closeNov 9, 2026, 4:00 PM EST
0.83 Day range 0.857
0.685 52-week range 1.08
- YTD
- -21.23%
- 1 year
- -15.87%
News
seekingalpha.com Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Q3 2026 Earnings Call Transcript Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Q3 2026 Earnings Call Transcript
prnewswire.com Genomma Lab Internacional Announces Results for the Third Quarter 2026 MEXICO CITY, Oct. 21, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the third quarter 2026.
seekingalpha.com Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Q2 2026 Earnings Call Transcript Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Q2 2026 Earnings Call Transcript
seekingalpha.com Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Q1 2026 Earnings Call Transcript Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Q1 2026 Earnings Call Transcript
prnewswire.com Genomma Lab Internacional Announces Results for the First Quarter 2026 MEXICO CITY, April 22, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter 2026.
prnewswire.com Genomma Lab Internacional S.A.B. de C.V. First Quarter 2026 Earnings Results Conference Call MEXICO CITY, April 13, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company") today announced that it will report its First Quarter 2026 Earnings…
seekingalpha.com Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Q4 2025 Earnings Call Transcript Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Q4 2025 Earnings Call Transcript
prnewswire.com Genomma Lab Internacional Announces Results for the Fourth Quarter and Full Year 2025 MEXICO CITY, Feb. 25, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the fourth quarter and full year 2025.
prnewswire.com Genomma Lab Internacional S.A.B. de C.V. Fourth Quarter 2025 Earnings Results Conference Call MEXICO CITY, Jan. 30, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company") today announced that it will report its Fourth Quarter 2025 Earnings…
prnewswire.com GENOMMA LAB INTERNACIONAL ANNOUNCES FOURTEENTH DIVIDEND PAYMENT MEXICO CITY , Dec. 23, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product…
prnewswire.com GENOMMA LAB INTERNACIONAL ANNOUNCES FOURTEENTH DIVIDEND PAYMENT MEXICO CITY , Dec. 9, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product…
seekingalpha.com Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Q3 2025 Earnings Call Transcript Genomma Lab Internacional, S.A.B. de C.V. (OTCPK:GNMLF) Q3 2025 Earnings Call October 23, 2025 1:00 PM EDT Company Participants Christianne Ibañez - Head of Investor Relations Marco Sparvieri - Chief…
prnewswire.com Genomma Lab Internacional Announces Results for the Third Quarter 2025 MEXICO CITY , Oct. 22, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the third quarter of 2025.
prnewswire.com Genomma Lab Internacional S.A.B. de C.V. Third Quarter 2025 Earnings Results Conference Call MEXICO CITY , Oct. 8, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company") today announced that it will report its Third Quarter 2025 Earnings…
prnewswire.com Genomma Lab Internacional Announces Results for the Second Quarter 2025 MEXICO CITY , July 23, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the second quarter of 2025.
prnewswire.com GENOMMA LAB INTERNACIONAL ANNOUNCES TWELFTH DIVIDEND PAYMENT MEXICO CITY , June 23, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product…
prnewswire.com GENOMMA LAB INTERNATIONAL INFORMS TOTAL PREPAYMENT OF "LAB 23" UNSECURED LOCAL BOND (CEBUR) MEXICO CITY , June 12, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of Mexico's leading pharmaceutical and personal care companies…
prnewswire.com Genomma Lab successfully issued the LAB 25 and LAB 25-2 unsecured bonds (Cebures) for a total amount of $1.2 billion pesos, which will be used to prepay liabilities, including the full early amortization of the LAB 23 bond The 6- and 7-year tranches were oversubscribed by 1.25 times the total amount offered MEXICO CITY , June 4, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab"…
prnewswire.com Genomma Lab Internacional Announces Results for the First Quarter 2025 MEXICO CITY , April 30, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2025.
prnewswire.com Genomma Lab Internacional S.A.B. de C.V. First Quarter 2025 Earnings Results Conference Call MEXICO CITY , March 31, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company") today announced that it will report its First Quarter 2025 Earnings…
benzinga.com Stocks That Hit 52-Week Highs On Wednesday